This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Valerian Root
Valeriana officinalis is the most heavily marketed botanical sedative in the West, but the cleaner you look at the data, the smaller the signal gets.
Aliases (6)
Overview
What is Valerian Root?
Valeriana officinalis is the most heavily marketed botanical sedative in the West, but the cleaner you look at the data, the smaller the signal gets. Bent's 2006 meta-analysis found a modest dichotomous "improved sleep" effect (RR ~1.8) on subjective questionnaires; the same review flagged heavy publication bias. Taibi 2009 — the cleanest PSG trial — was outright null on objective sleep latency, total sleep time, and actigraphy. Smell is universally bad (isovaleric acid plus valerenic acid), the morning hangover is real in a meaningful subset of users, and the bioactive complex is so unstable that two bottles of "300mg standardized extract" can differ 5-fold in valepotriate content. For a 20yo MMA athlete with V4 already covering magnesium glycinate + apigenin + L-theanine + sleep hygiene + glycine, valerian is strictly inferior. SKIP for Dylan. Possible-use for sleep-onset insomnia where modern tools have failed, never as a first move.
Pharmacokinetics
Peptide Interactions
better RCT support as combo than monotherapy. Ze 91019 product is the canonical formulation; works on similar GABA-A pathway.
anxiety + sleep combo. Adds mild serotonergic + acetylcholine modulation.
additive GABAergic + NMDA antagonist relaxation. The single best mineral co-stack for sleep.
alpha-wave promotion + glutamate modulation. Smooths anxiety dimension.
another GABA-A PAM. Similar mechanism, modest dose-additive sedation.
separate mechanism (NMDA glycine site, body-temp drop). Stacks cleanly.
Additive GABAergic depression; theoretical respiratory risk at high combined doses. Clinical interaction reports exist.
Same logic. Skip.
Same logic plus much stronger CNS depression; combined effect = oversedation, motor impairment.
Additive sedation; multiple case reports of profound somnolence.
Additive respiratory depression risk at high doses.
Additive sedation + anticholinergic load.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 6
Side Effects
- 1Smell/taste/burp — Universal. Isovaleric acid + valerenic acid metabolites smell like sweaty gym socks. Capsules contain it; tinctures and teas don't.
- 2Mild morning grogginess — 10–20% of users; worse at >600mg or with concentrated extracts. The "valerian hangover."
- 3GI upset — nausea, abdominal cramps, loose stools. ~5-10% of users at standard doses.
- 4Headache — uncommon, usually mild.
- 5Paradoxical agitation/insomnia/anxiety — small fraction; sometimes resolves with dose reduction, sometimes a permanent non-response.
- 6Vivid dreams or unusual dreaming — reported in community surveys; mechanism unclear (possibly REM rebound or 5-HT contribution).
When to Stop
- Hepatotoxicity — Sporadic case reports of valerian-associated liver injury (elevated ALT/AST, occasionally cholestasis). Most reports are with multi-herb products (e.g., "Sleepytime + Valerian" combos, kava-valerian stacks) — usually multi-herb confounded. Direct causation in monotherapy is uncommon. Recommendation: avoid in known liver disease; monitor LFTs if using chronically with other hepatically-cleared compounds.
- Withdrawal-like syndrome on abrupt discontinuation — At least one case report (Garges 1998) described autonomic withdrawal symptoms after stopping high-dose chronic valerian. Genuine GABAergic withdrawal is theoretically plausible but extremely rare at OTC doses.
- Cardiovascular interactions — Occasional bradycardia/hypotension cases, usually with multi-CNS-depressant context.
- Allergic reactions — Rare; dermatitis from topical contact more common than systemic.
- Pregnancy / breastfeeding: Considered safe within typical OTC limits — no teratogenicity signals in animal or human data. Defer to OB if a Dylan-archetype partner is pregnant; pregnant individuals can use 400-600mg short-term for sleep with conservative caution.
- Children: Not recommended <12; some pediatric trials in 4-12yo use 320mg/day with reported safety, but data thin. Default no.
- Elderly: Use with care — falls risk from mild sedation; LFT monitoring if chronic.
- Liver disease: Avoid — hepatotoxicity case reports plus complex hepatic metabolism makes it the wrong herb for compromised liver.
- Pre-surgical: Hold ≥2 weeks before elective surgery — additive sedation with general anesthetics, possible GABA-A interaction with benzodiazepine premedication, theoretical bleeding risk via valepotriates.
References
Bent S et al. 2006 — Valerian for sleep: systematic review and meta-analysis (Am J Med)
16-RCT meta; RR ~1.8 for subjective sleep improvement; flagged publication bias.
View StudyTaibi DM et al. 2009 — Randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep (Sleep Med)
Null PSG/actigraphy/subjective trial in older women with insomnia; the cleanest negative data in the literature.
View StudyFernández-San-Martín MI et al. 2010 — Effectiveness of valerian on insomnia: meta-analysis of RCTs (Sleep Med)
18-RCT meta-analysis; dichotomous benefit RR ~1.4; quantitative latency reduction non-significant.
View StudyShinjyo N et al. 2020 — Valerian root in treating sleep problems and associated disorders: systematic review and meta-analysis (J Evid Based Integr Med, PMID 33086877)
Modern meta; whole-root at 450-1410mg ≥4 weeks more consistent; anxiety subgroup benefits more.
View StudyRecent herbal-medicines synthesis for insomnia (2024, PMID 38359657)
Network meta-analysis context; ashwagandha and lavender outrank valerian.
View StudyExamine.com — Valerian comprehensive review
Continuously updated effect grades and evidence summaries.
View StudyNCCIH — Valerian fact sheet (NIH)
Government clinical reference, hepatotoxicity considerations, safety in pregnancy.
View StudyDonath F et al. 2000 — Critical evaluation of the effect of valerian extract on sleep structure and sleep quality (Pharmacopsychiatry)
Early PSG trial; modest sleep-latency reduction with 600mg dried valerian over 14 days.
View StudyKhom S et al. 2007 — Valerenic acid potentiates and inhibits GABA-A receptors via β3-selective binding
Mechanistic receptor pharmacology; established the β3 selectivity.
View StudyGarges HP et al. 1998 — Cardiac complications and delirium with valerian root withdrawal (JAMA case report)
Single case of GABAergic-withdrawal-like syndrome; the cited basis for theoretical dependence risk.
View StudyAndreatini R et al. 2002 — Effect of valepotriates on generalized anxiety disorder (Phytother Res)
Small RCT in generalized anxiety; modest signal.
View StudyMüller D et al. 2006 — Valerian-lemon balm combination for menopausal sleep disturbance
Combo product trial.
View StudyWikipedia — Valerian (herb)
) — General reference; pharmacology, history, regulatory.
View StudyLiverTox — Valerian
NIH-curated hepatotoxicity profile; case reports analyzed.
View StudyLatest research
- reviewHerbal medicines for insomnia — recent network meta-analysis contextRecent network/synthesis reviews place valerian below ashwagandha and lavender preparations for sleep-quality endpoints in head-to-head comparisons.
- metaValerian root in treating sleep problems and associated disorders — systematic review and meta-analysisWhole-root preparations at 450–1410 mg/day for 4–8 weeks show more consistent subjective benefit than short-course or aqueous extracts; objective PSG measures rarely reach significance.
- metaEffectiveness of valerian on insomnia — meta-analysis of randomized placebo-controlled trialsPooled qualitative dichotomous benefit (RR ~1.4 for 'improved sleep') with substantial heterogeneity; quantitative sleep-onset latency improvement not significant.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.